SEC 13F Intelligence

Aldebaran Capital, LLC / ACRS

Aldebaran Capital, LLC’s Aclaris Therapeutics Inc Position

Does Aldebaran Capital, LLC own Aclaris Therapeutics Inc (ACRS)? Yes — 947.2K shares worth $4M (+2.72% of its 13F portfolio) as of Q1 2026, down from 954.3K shares the prior filed quarter.

Position Value
$4M
Q1 2026
Shares
947.2K
% of Portfolio
+2.72%
Quarters Held
8
currently held

Position History ACRS

Reported value by quarter
Q2 ’24: $943,967Q2 ’24Q3 ’24: $1MQ3 ’24Q4 ’24: $3MQ4 ’24Q1 ’25: $2MQ1 ’25Q2 ’25: $1MQ2 ’25Q3 ’25: $2MQ3 ’25Q4 ’25: $3MQ4 ’25Q1 ’26: $4MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026947.2K$4M+2.72%
Q4 2025954.3K$3M+2.58%
Q3 2025987.7K$2M+1.72%
Q2 2025993.7K$1M+1.39%
Q1 20251.01M$2M+1.46%
Q4 20241.02M$3M+2.40%
Q3 20241.04M$1M+1.10%
Q2 2024858.2K$943,967+0.88%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Aldebaran Capital, LLC’s full portfolio or all institutional holders of ACRS.